BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26465200)

  • 1. A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
    Lee BH; Indran IR; Tan HM; Li Y; Zhang Z; Li J; Yong EL
    Endocrinology; 2016 Jan; 157(1):382-94. PubMed ID: 26465200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Dietary Fatty Acid, Decanoic Acid, Prevent Polycystic Ovary Syndrome?
    Guo C
    Endocrinology; 2016 Jan; 157(1):46-7. PubMed ID: 26717473
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
    Indran IR; Lee BH; Yong EL
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of human 3β-hydroxysteroid dehydrogenase type 2 for steroid hormone biosynthesis by starvation and cyclic AMP stimulation: studies in the human adrenal NCI-H295R cell model.
    Udhane S; Kempna P; Hofer G; Mullis PE; Flück CE
    PLoS One; 2013; 8(7):e68691. PubMed ID: 23874725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.
    Kempná P; Hofer G; Mullis PE; Flück CE
    Mol Pharmacol; 2007 Mar; 71(3):787-98. PubMed ID: 17138841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor Nur77 in steroidogenic cells.
    Martin LJ; Tremblay JJ
    Endocrinology; 2005 Feb; 146(2):861-9. PubMed ID: 15498889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.
    Hirsch A; Hahn D; Kempná P; Hofer G; Nuoffer JM; Mullis PE; Flück CE
    Endocrinology; 2012 Sep; 153(9):4354-66. PubMed ID: 22778212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.
    Pyun BJ; Yang H; Sohn E; Yu SY; Lee D; Jung DH; Ko BS; Lee HW
    Molecules; 2018 May; 23(5):. PubMed ID: 29757997
    [No Abstract]   [Full Text] [Related]  

  • 9. Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS.
    Yu J; Liu Y; Zhang D; Zhai D; Song L; Cai Z; Yu C
    J Endocrinol; 2019 Jan; ():. PubMed ID: 30650063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
    Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
    Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
    Medeiros SF; Barbosa JS; Yamamoto MM
    J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orphan nuclear receptor NR4A1 regulates transcription of key steroidogenic enzymes in ovarian theca cells.
    Li M; Xue K; Ling J; Diao FY; Cui YG; Liu JY
    Mol Cell Endocrinol; 2010 May; 319(1-2):39-46. PubMed ID: 20083153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.